Ubs Asset Management Americas Inc Guardant Health, Inc. Transaction History
Ubs Asset Management Americas Inc
- $379 Billion
- Q1 2025
A detailed history of Ubs Asset Management Americas Inc transactions in Guardant Health, Inc. stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 2,777,040 shares of GH stock, worth $138 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
2,777,040
Previous 2,612,777
6.29%
Holding current value
$138 Million
Previous $79.8 Million
48.21%
% of portfolio
0.03%
Previous 0.02%
Shares
23 transactions
Others Institutions Holding GH
# of Institutions
393Shares Held
121MCall Options Held
1.43MPut Options Held
2.37M-
Vanguard Group Inc Valley Forge, PA12.1MShares$598 Million0.01% of portfolio
-
Black Rock Inc. New York, NY11.2MShares$557 Million0.01% of portfolio
-
Deep Track Capital, LP Greenwich, CT5.44MShares$270 Million8.11% of portfolio
-
Capital International Investors Los Angeles, CA5.15MShares$255 Million0.04% of portfolio
-
Baillie Gifford & CO5.06MShares$251 Million0.19% of portfolio
About Guardant Health, Inc.
- Ticker GH
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 102,220,000
- Market Cap $5.06B
- Description
- Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...